Երկիր: Հունգարիա
Լեզու: անգլերեն
Աղբյուրը: HMA (Heads of Medicines Agencies)
carprofen 120 mg
Sogeval
QM01AE91
Chewable tablet
carprofen
Dogs
2011-08-24
1. NAME OF THE VETERINARY MEDICINAL PRODUCT DOLAGIS 120 mg chewable tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: One tablet contains: Carprofen ..................................................................... 120 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet. Clover-shaped scored beige tablet The tablet can be divided into four equal parts. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In the dog: Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. As a follow-up to parenteral analgesia in the management of post-operative pain. 4.3 CONTRAINDICATIONS Do not use in pregnant and lactating bitches. Do not use in dogs aged less than 4 months in the absence of specific data. Do not use in cats. Do not use in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia. Do not use in case of hypersensitivity to the active substance, to other NSAID and to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES See sections 4.3 and 4.5. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased ren al Կարդացեք ամբողջական փաստաթուղթը